03:27 PM Abstract No. 434 Comparison of tumor and liver enhancement on preinterventional MDCT, CBCT, SPECT, and postinterventional PET in patients with HCC undergoing SIRT

In radioembolization (SIRT) the activity of tumor and liver is estimated from Technetium99-Human-Serum-Albumin Single Photon Emission Computed Tomography (SPECT), but relative contrast differences can also be calculated from arterial phase Multidetector Computed Tomography (MDCT) or parenchymal phase Cone-beam Computed Tomography (CBCT) (1). The aim of this study was to investigate the agreement of Tumor-Liver-Enhancement-Ratio (TLER) of preinterventional MDCT, CBCT, and SPECT with postinterventional Yttrium90 Positron Emission Tomography (PET) serving as gold standard for dose distribution assessment.
Source: Journal of Vascular and Interventional Radiology : JVIR - Category: Radiology Authors: Tags: Scientific Session 45: Y-DeLiver (Radioembolization III) Source Type: research